 |
| july
8, 2026 |
| Regional
intelligence on Drugs, Diagnostics,
Devices & Digital Health |
|
|
|
* may need subscription to view |
|
BIG4BIO
CEO WEEKLY Q&A:
Jehee Suh, CEO, Inocras |
| In
this Q&A, Suh discusses what drew him
to Inocras, why whole-genome analysis is
approaching an inflection point, how
Inocras is building the evidence base for
broader clinical adoption, and what it
will take for whole-genome-based care to
become the new standard in oncology and
rare disease. More |
|
|
 |
| Biotech’s
most flexible vivarium lab space
to launch and scale studies. |
|
Learn More
→ |
|
|
- Absentia Labs: Digital Liver Model Becomes
First AI Drug Development Tool Accepted Into
FDA Qualification Program More
- BostonGene: Named “Overall AI-based
Analytics Company of the Year” in 2026 AI
Breakthrough Awards Program More
- EMD Serono: FDA Breakthrough Therapy
Designation for Enpatoran in Lupus Patients
With Active Skin Manifestations More
- Insilico: Initiates Phase III Clinical Trial
for Rentosertib, Its AI-Empowered TNIK
Inhibitor for Idiopathic Pulmonary Fibrosis More
- Iterative Health and Gastroenterology
Associates of New Jersey: Partner to Expand
Patient Access to Advanced GI Research More
- New England Biolabs: Launches the NEBNext
Companion Module for Oxford Nanopore
Technologies Direct RNA Sequencing More
- RoslinCT
and BlueRock Therapeutics: Partner to Expand
Access to Clinical-Grade Pluripotent Cell
Lines for Cell Therapy Developers More
- Seres Therapeutics: Early Clinical Data
Showing Potential for SER-155 in Immune
Checkpoint Inhibitor-Related Enterocolitis
(irEC), a Frequent Adverse Reaction That
Forces Many Patients to Halt Cancer Treatment
More
- Wave Life Sciences: Singapore Court Hearing,
to be Held on July 14, 2026 to Approve Scheme
of Arrangement for Redomiciliation More
|
|
 |
Charles
River CFO
Keeping It Steady During a
Company-Defining Moment |
|
Learn More
→ |
|
|
- BioPharmCatalyst Weekly Watchlist: Key PDUFA
and Regulatory Catalysts for the Next 6 Months
More
- Bone Biologics: Up to $9.0 Million Private
Placement Priced At-The-Market Under Nasdaq
Rules More
- Boston VC Firms Invest in Pediatric Care
Company More*
- Chemomab Therapeutics and Scipher
Medicine: Merger Agreement to Advance
Nebokitug in an AI-Powered Phase 2 Trial in
Rheumatoid Arthritis More
- Lifeward: Secures Growth Capital to
Accelerate Commercial Expansion With Up to
$11.2 Million in Strategic Financing More
- More on Vertex’s $10B Crinetics Deal
Marking Its Clearest Step Yet Toward
Biopharma’s Top Ranks More*
More*
More*
More
- O’Shaughnessy Ventures Awards Fellowship to
MIT Bioengineering Researcher Developing
Injectable Vascular Therapy
More
- Why Is Agios Pharma Stock Soaring Tuesday? More
|
|
|
 |
Pace®
Life Sciences
The CDMO That Takes You Further.
Your partner for Product
Development, Manufacturing,
Analytical Testing, Regulatory
Consulting & Operational
Support. |
|
Learn More
→ |
|
|
- A Decade on the Map: How Big4Bio’s
Regions Moved in GEN’s Top 10 Biopharma
Clusters, 2016–2026 More
- AI Tackles Tuberculosis, Identifies Drugs
That Penetrate Bacteria Membrane More
- Beyond Immunosuppression: The Rise of T-Cell
Engagers for Autoimmune Disease | Dr. Jeffrey
Jones, MD, MPH - Chief Medical Officer,
Cullinan Therapeutics Podcast
- Big4Bio CEO Weekly Q&A: Jehee
Suh, CEO, Inocras More
- More on Hengrui, Kailera’s GLP-1 Pill
Posting Encouraging Efficacy but High Side
Effect Rates in Late-Stage China Trials More*
More*
More
More
- More on Whitehawk Swooping In for Five ADCs
via Development Deal With China’s Biocytogen More
- Subscribe to LifeSci Startup for
Updates on US Startups More
- Three Biotech Tenants Move Into Former
Athenahealth HQ More*
- Tracing Evolution of Vaccine for Cancer,
Malaria More
- ZoBio: Expert Q&A More
|
|
- Aura Biosciences: Appointment of Jeremy
Bender, Ph.D., M.B.A., to Board of Directors More
- ICYMI: A View From the Trenches - Biotech
Series A in 2026 More
- OPPORTUNITY: Chief Executive Officer,
Cambridge, MA
More
- OPPORTUNITY: Chief Financial Officer, Pine
Brook, NJ / Hybrid
More
- OPPORTUNITY: President, Business
Development, New England Region, Remote More
- OPPORTUNITY: Vice President, Global BD,
Remote
More
- Slone Partners: How to De-Risk
Executive Hiring Decisions in Life Sciences
and Healthcare
More
- Stipple Bio: Appoints Biopharma Business
Development Leader Roland Gendron as Chief
Business Officer More
- Tolion Health AI Appoints Pioneering AI
Scientist Josef Šivic, PhD, as Chief
Strategy Officer to Accelerate AI-Driven
Brain Health Innovation More
- Vor Bio: Appoints David Zaccardelli to Board
of Directors
More
- WHOOP:
Names Dirk-Jan "DJ" van Hameren Chief
Marketing Officer as Member Base Surpasses 3
Million More
|
|
|
DISCOVER COMPANIES |
|
Big4Bio: Boston Life Science
Company Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
 |
|
|
|
 |
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:Boston,
all rights reserved 2026
© 2026
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|
